238 related articles for article (PubMed ID: 6705139)
1. Modification of the development of N-nitrosomorpholine-induced hepatic lesions by 2-acetylaminofluorene, phenobarbital and 4,4'-diaminodiphenylmethane: a sequential histological and histochemical analysis.
Ito N; Moore MA; Bannasch P
Carcinogenesis; 1984 Mar; 5(3):335-42. PubMed ID: 6705139
[TBL] [Abstract][Full Text] [Related]
2. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion.
Schulte-Hermann R; Timmermann-Trosiener I; Barthel G; Bursch W
Cancer Res; 1990 Aug; 50(16):5127-35. PubMed ID: 2379175
[TBL] [Abstract][Full Text] [Related]
3. Enzyme histochemical and morphological phenotype of amphophilic foci and amphophilic/tigroid cell adenomas in rat liver after combined treatment with dehydroepiandrosterone and N-nitrosomorpholine.
Weber E; Moore MA; Bannasch P
Carcinogenesis; 1988 Jun; 9(6):1049-54. PubMed ID: 2967125
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of NNM-induced carcinogenesis in the rat liver by phenobarbital: a combined morphological and enzyme histochemical approach.
Moore MA; Hacker HJ; Kunz HW; Bannasch P
Carcinogenesis; 1983; 4(4):473-9. PubMed ID: 6132686
[TBL] [Abstract][Full Text] [Related]
5. Nonlinearities in 2-acetylaminofluorene exposure responses for genotoxic and epigenetic effects leading to initiation of carcinogenesis in rat liver.
Williams GM; Iatropoulos MJ; Wang CX; Jeffrey AM; Thompson S; Pittman B; Palasch M; Gebhardt R
Toxicol Sci; 1998 Oct; 45(2):152-61. PubMed ID: 9848122
[TBL] [Abstract][Full Text] [Related]
6. Comparison of mode of action of four hepatocarcinogens: a model-based approach.
Groos J; Bannasch P; Schwarz M; Kopp-Schneider A
Toxicol Sci; 2007 Oct; 99(2):446-54. PubMed ID: 17636249
[TBL] [Abstract][Full Text] [Related]
7. Effects of the peroxisome proliferator di(2-ethylhexyl)phthalate on enzymes in rat liver and on carcinogen-induced liver altered foci in comparison to the promoter phenobarbital.
Maruyama H; Tanaka T; Williams GM
Toxicol Pathol; 1990; 18(2):257-67. PubMed ID: 1975953
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of neoplastic development in rat liver, kidney, oesophagus and forestomach by 4,4'-diaminodiphenylmethane administration.
Tsuda H; Ogiso T; Hasegawa R; Imaida K; Masui T; Ito N
Carcinogenesis; 1987 May; 8(5):719-22. PubMed ID: 3581430
[TBL] [Abstract][Full Text] [Related]
9. Modulatory interaction between initial clofibrate treatment and subsequent administration of 2-acetylaminofluorene or sodium phenobarbital on glutathione S-transferase positive lesion development.
Mutai M; Tatematsu M; Aoki T; Wada S; Ito N
Cancer Lett; 1990 Feb; 49(2):127-32. PubMed ID: 2306705
[TBL] [Abstract][Full Text] [Related]
10. Natural killer activity in a medium-term multi-organ bioassay for carcinogenesis.
Spinardi AL; Kaneno R; Rodrigues MA; Salvadori DM; Rocha NS; Barbisan LF; Ribeiro LR; de Camargo JL
Jpn J Cancer Res; 1999 Jan; 90(1):101-7. PubMed ID: 10076572
[TBL] [Abstract][Full Text] [Related]
11. Influence of phenobarbital on glycogen metabolism of rat liver pretreated with N-nitrosomorpholine.
Mayer D; Moore MA; Bannasch P
Carcinogenesis; 1983; 4(7):931-3. PubMed ID: 6307540
[TBL] [Abstract][Full Text] [Related]
12. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced in stop experiments by oral exposure to N-nitrosomorpholine.
Weber E; Bannasch P
Carcinogenesis; 1994 Jun; 15(6):1227-34. PubMed ID: 8020160
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effects of trans-4-acetylaminostilbene and 2-acetylaminofluorene at the level of tumor initiation.
Hammerl R; Kirchner T; Neumann HG
Chem Biol Interact; 1994 Oct; 93(1):11-28. PubMed ID: 7915206
[TBL] [Abstract][Full Text] [Related]
14. Effects of dietary selenium concentration on the development of enzyme-altered liver foci and hepatocellular carcinoma induced by diethylnitrosamine or N-acetylaminofluorene in rats.
LeBoeuf RA; Laishes BA; Hoekstra WG
Cancer Res; 1985 Nov; 45(11 Pt 1):5489-95. PubMed ID: 2865004
[TBL] [Abstract][Full Text] [Related]
15. Phenobarbital as a promoter in the initiation/selection process of experimental rat hepatocarcinogenesis.
Lans M; de Gerlache J; Taper HS; Préat V; Roberfroid MB
Carcinogenesis; 1983; 4(2):141-4. PubMed ID: 6825204
[TBL] [Abstract][Full Text] [Related]
16. Induced drug resistance inhibits selection of initiated cells and cancer development.
Rissler P; Torndal UB; Eriksson LC
Carcinogenesis; 1997 Apr; 18(4):649-55. PubMed ID: 9111195
[TBL] [Abstract][Full Text] [Related]
17. Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice.
Ward JM; Rice JM; Creasia D; Lynch P; Riggs C
Carcinogenesis; 1983 Aug; 4(8):1021-9. PubMed ID: 6872148
[TBL] [Abstract][Full Text] [Related]
18. Morphological alterations and DNase deficiency in phenobarbital promotion of N-nitrosomorpholine initiated rat hepatocarcinogenesis.
Taper HS; Lans M; de Gerlache J; Fort L; Roberfroid M
Carcinogenesis; 1983; 4(2):231-4. PubMed ID: 6825212
[TBL] [Abstract][Full Text] [Related]
19. Changes in levels of ADP-ribose polymers in rat liver during 2-acetylaminofluorene-induced hepatocarcinogenesis.
Kiehlbauch CC; Kosanke SD; Ringer DP
Carcinogenesis; 1993 Jul; 14(7):1435-40. PubMed ID: 8330362
[TBL] [Abstract][Full Text] [Related]
20. Distinction between liver neoplasm promoting and syncarcinogenic effects demonstrated by exposure to phenobarbital or diethylnitrosamine either before or after N-2-fluorenylacetamide.
Williams GM; Furuya K
Carcinogenesis; 1984 Feb; 5(2):171-4. PubMed ID: 6697434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
